A share price of Vertex Pharmaceuticals, Inc [VRTX] is currently trading at $499.88, up 5.73%. Until recently, the best way to gauge how the stock has performed was to look at its short-term value. The VRTX shares have gain 6.28% over the last week, with a monthly amount glided 11.43%, and seem to be holding up well over a long-time horizon.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
From an analyst’s perspective:
On August 05, 2024, downgrade downgraded it’s rating to Equal Weight and revised its price target to $509 on the stock. Redburn Atlantic started tracking the stock assigning a Buy rating and suggested a price target of $545 on June 27, 2024. Evercore ISI upgraded its rating to a Outperform but $438 remained the price target by the analyst firm on April 11, 2024. Wolfe Research started tracking with a Outperform rating for this stock on February 15, 2024, and assigned it a price target of $515. In a note dated February 06, 2024, Evercore ISI downgraded an In-line rating on this stock and boosted its target price from $436 to $438.
Vertex Pharmaceuticals, Inc experienced fluctuations in its stock price throughout the past year between $341.90 and $510.64. Currently, Wall Street analysts expect the stock to reach $403.33 within the next 12 months. Vertex Pharmaceuticals, Inc [NASDAQ: VRTX] shares were valued at $499.88 at the most recent close of the market. An investor can expect a potential drop of -19.31% based on the average VRTX price forecast.
Analyzing the VRTX fundamentals
Trailing Twelve Months sales for Vertex Pharmaceuticals, Inc [NASDAQ:VRTX] were 10.61B which represents 11.74% growth. Gross Profit Margin for this corporation currently stands at 0.86% with Operating Profit Margin at -0.03%, Pretax Profit Margin comes in at 0.02%, and Net Profit Margin reading is -0.05%. To continue investigating profitability, this company’s Return on Assets is posted at -0.02, Equity is -0.03 and Total Capital is -0.02. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.11.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 481.52 points at the first support level, and at 463.16 for the second support level. However, for the 1st resistance point, the stock is sitting at 510.72, and for the 2nd resistance point, it is at 521.56.
Ratios To Look Out For
To put it in perspective, the Current Ratio for Vertex Pharmaceuticals, Inc [NASDAQ:VRTX] is 2.47. As well, the Quick Ratio is 2.20, while the Cash Ratio is 1.32. Considering the valuation of this stock, the price to sales ratio is 12.16, the price to book ratio is 8.24.
Transactions by insiders
Recent insider trading involved Biller Jonathan, EVP and Chief Legal Officer, that happened on Oct 02 ’24 when 999.0 shares were sold. Officer, Biller Jonathan completed a deal on Oct 02 ’24 to buy 999.0 shares. Meanwhile, Executive Chairman LEIDEN JEFFREY M sold 3784.0 shares on Aug 30 ’24.
